301101SZSE

2025 Annual Report of Independent Director (Sun Jian - Resigned)

✨ AI Summary

This report outlines Sun Jian's performance as an independent director of Mingyue Lens Co., Ltd. during 2025. He attended all board and shareholder meetings, ensuring compliance with legal requirements and protecting shareholder interests. Key decisions included the reappointment of the auditing firm and the election of the third board of directors. Sun Jian emphasizes the importance of maintaining effective communication with shareholders, particularly small and medium-sized investors.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Mingyue Lens Co., Ltd. 2025 Annual Report of Independent Director (Sun Jian)

Dear shareholders and representatives:

Hello! I am Sun Jian, serving as the independent director of Mingyue Lens Co., Ltd. (hereinafter referred to as "the Company") on the second board of directors. During my tenure in 2025, I strictly adhered to the relevant laws and regulations, including the Company Law of the People's Republic of China, the Securities Law of the People's Republic of China, the Shenzhen Stock Exchange GEM Listing Rules, the Self-Regulatory Guidelines for Listed Companies on the Shenzhen Stock Exchange No. 2 - Standardized Operation of GEM Listed Companies, the Corporate Governance Guidelines for Listed Companies, and the Management Measures for Independent Directors of Listed Companies, as well as the Company’s Articles of Association and the Independent Director Work System. I diligently fulfilled my duties, actively attended board meetings, carefully reviewed board proposals, and effectively performed my role as an independent director and member of various committees, supervising the Company’s standardized operations and safeguarding the legitimate rights and interests of shareholders, especially small and medium-sized shareholders.

On December 16, 2025, the Company’s board of directors completed its re-election, and I ceased to serve as an independent director and member of various committees from that date. I hereby report on my performance as an independent director during my tenure in 2025 as follows:

1. Basic Information of the Independent Director

I, Sun Jian, born in 1972, hold American nationality and a Ph.D. from the University of Chicago. I have previously served as the Executive Managing Director of Fixed Income at Morgan Stanley in New York, Managing Director at XE Hedge Fund in New York, Manager at BNP Paribas, and Professor at the School of Mathematical Sciences at Fudan University, as well as Director of the Quantitative Center at the Fudan University Financial Research Institute. From August 2020 to December 2025, I served as the independent director of the Company. During my tenure, I met the independence requirements stipulated in Article 6 of the Management Measures for Independent Directors of Listed Companies and did not encounter any situations affecting my independence.

2. Overview of Independent Director's Annual Performance

(1) Attendance at Board and Shareholder Meetings

During my tenure in 2025, the Company held 5 board meetings and 4 shareholder meetings, and I personally attended all 5 board meetings and 4 shareholder meetings. For the matters discussed at the board meetings, I proactively investigated and obtained the necessary information for decision-making, fully understood the Company's operational status, and utilized my professional knowledge and industry experience for analysis and decision-making, voting independently and prudently on various proposals.

I believe that the convening and procedural processes of the board and shareholder meetings during my tenure complied with relevant laws and regulations, and the resolutions formed were legal and effective, without harming the interests of all shareholders, especially small and medium-sized shareholders. I expressed my support for all board proposals after careful review (except for those requiring abstention), with no objections, dissent, or abstentions. The specific attendance details during the reporting period are as follows:

Meeting TypeAttendance CountRequired Attendance CountOn-site Attendance CountCommunication Attendance CountProxy Attendance CountAbsence CountConsecutive Absences
Board Meeting553200No
Shareholder Meeting440000No

(2) Attendance at Special Independent Director Meetings

During my tenure in 2025, the Company did not hold any special meetings for independent directors.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.